We’re now less than two weeks away from our annual biotech bash in Boston, but we’ve got a few new tidbits to share—two new speakers have come aboard to round out the program.
The first new name is Tillman Gerngross, the Dartmouth College professor, founder of antibody shop Adimab, and scientist-turned-scientific businessman, as we wrote in this profile a few years ago. The second is Samantha Singer, the chief operating officer of the Broad Institute of MIT and Harvard and a former Biogen executive.
They’ll both be participating in different discussions we’ve lined up for “What’s Hot in Boston Biotech” on April 6 at Biogen’s campus in Cambridge, MA. Check out the agenda here, which will include a combination of solo spotlight talks, candid discussions, entrepreneurial stories, and more from some of the Boston area’s top executives, investors, and scientists.
This is shaping up to be Xconomy’s biggest biotech event yet. If you haven’t joined up yet, you can still grab a discount if you register here by March 30—see you all soon at Biogen.
